Novartis Us Foundation
The Novartis US Foundation is a private grantmaking foundation incorporated in Delaware in 1965 and based in East Hanover, New Jersey. The foundation adopted its current name in 1997 following a merger with the Ciba Educational Foundation, Inc. It operates as a company-sponsored foundation and is classified as a 501(c)(3) charitable organization.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$16.8M
+12.8% YoY
Annual Giving
$13.8M
+35.4% YoY
Grant Count
9
+12.5% YoY
Avg Grant Size
$1.5M
+20.4% YoY
Mission & Focus Areas
The mission of the Novartis US Foundation is to improve health in underserved communities in the United States by creating innovative and sustainable solutions to expand access to healthcare and build trust within the healthcare system.
The foundation supports sustainable programs and partnerships that:
- Strengthen health systems
- Eliminate barriers to quality health services
- Enhance local communities
Primary funding areas include education and public affairs initiatives.
Grantmaking
The foundation matches contributions made by its employees to nonprofit organizations. Based on recent fiscal data, the foundation awarded approximately $10.2 million in grants in the previous year across approximately 2,078 grants, with an average grant size of approximately $4,000.
Grant Range
of approximately $4,000.
Average Grant
of approximately $4,000.
Ready to take the next step with Novartis Us Foundation?
Geographic Focus
Where this funder awards grants
The foundation supports projects across multiple states and cities in the United States, including:
- California
- Georgia
- Illinois
- New Jersey
- Pennsylvania
- Tennessee
- Virginia
- Washington DC
Specific cities where the foundation has funded initiatives include Alexandria, Atlanta, Chicago, Los Angeles, and Washington DC.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
Most Recent Financial Data (Fiscal Year 2024):
- Total Assets: $16.8 million
- Total Revenue: $12.5 million
- Total Expenses: $14.2 million
- Total Liabilities: $10.7 million
Prior Year Data (Fiscal Year 2023):
- Total Assets: $14.9 million
- Total Revenue: $11.1 million
- Total Expenses: $10.5 million
The foundation has demonstrated significant growth, with revenue increasing by an average of 43.2% annually over a four-year period.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $16,755,990 | $14,852,875 | $13,549,393 |
| Revenue | $12,468,613 | $11,098,253 | $11,748,476 |
| Expenses | $14,166,542 | $10,506,293 | $6,807,575 |
| Qualifying Distributions | $13,775,425 | $10,184,424 | $6,520,326 |
| Net Investment Income | $5,878,759 | $4,258,572 | $5,943,107 |
| Distributable Amount | $730,995 | $865,431 | $932,697 |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 9 recipients in 2024
Grant Size Distribution
41 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
Key personnel include:
- Patrice Matchaba - President
- David Hellmuth - Secretary
- Katherine Vazquez - Treasurer/Trustee
All key personnel serve without compensation.
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| JAMIE HUERTAS | SECRETARY | — | — |
| EDUARD MARTI | TREASURER | — | — |
| KRISTINA DIGRAVINA | ASSISTANT TREASURER | — | — |
| ASHLEY ATKINS | MANAGER | — | — |
| HAYLEY RAZLOZNIK | MANAGER | — | — |
| DAVID XIA | ASSISTANT TREASURER | — | — |
| DANIEL WIPFLI | ASSISTANT TREASURER | — | — |
| BINTA BEARD | PRESIDENT | — | — |
| MICHAEL L PEREZ | ASSISTANT SECRETARY | — | — |
Recent News & Activity
Recent developments and announcements
The Novartis US Foundation has been active in supporting health equity and diversity initiatives:
Novartis Lights A Beacon Of Hope For Diversity And InclusionThe foundation established a $5 million US COVID-19 Community Response Fund to address pandemic-related health disparities
Novartis and the Novartis US Foundation establish USD 5 million US COVID-19The foundation is engaged in the "Beacon of Hope" initiative, which focuses on supporting clinical trial diversity and breaking down economic and education barriers
The foundation has expanded partnerships with Historically Black Medical Schools to address systemic health disparities
Novartis expands Beacon of Hope through alliances with Historically BlackNovartis pledged a 10-year commitment with Morehouse School of Medicine and 26 Historically Black Colleges, Universities, Medical Schools, and other leading organizations to co-create effective, measurable solutions for health equity
Novartis strengthens commitment to Beacon of Hope initiative ...Related Funders
Similar funders by location and focus area
Laborers Intl Union of 472 Hcl
NEWARK, NJ
Assets
$61.5M
Grants
1
Total Given
$179K
The Community Chest of Englewood
ENGLEWOOD, NJ
Assets
$491K
Grants
5
Total Given
$38K
Margaret a Darrin Charitable Trust
FLORHAM PARK, NJ
Assets
$111.3M
Grants
61
Total Given
$6.9M
Anplr Religious Education Inc
PASSAIC, NJ
Assets
$19K
Grants
0
Total Given
—
New Digital Trade Coalition Ndtc
NORTH BERGEN, NJ
Assets
$300
Grants
0
Total Given
—
Stephen J Machuta Scholarship Trust
PENNINGTON, NJ
Assets
$1.9M
Grants
1
Total Given
$70K
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Novartis Us Foundation on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities